Vaccine candidates for Ebola, other filoviruses show promise
UH researchers have demonstrated the efficacy in monkeys of multiple vaccine candidates targeting three filoviruses causing life-threatening infections to humans.
UH researchers have demonstrated the efficacy in monkeys of multiple vaccine candidates targeting three filoviruses causing life-threatening infections to humans.
Vernon Ansdell leads the clinical subcommittee for the state’s joint task force.
The JABSOM Tropical Medicine Clinical Laboratory is serving those with limited access to healthcare and health insurance, as well as first responders and health care workers on the frontlines of the pandemic.
The Tropical Medicine Clinical Lab will begin accepting COVID-19 tests from its Kakaʻako clinic beginning October 19.
The National Institutes of Health R01 grants bring in at least $1 million in federal direct dollars, and another half million in indirect funding to UH Mānoa.
Axel Lehrer with the John A. Burns School of Medicine is working with Soligenix, Inc.
Virginia Hinshaw retired June 30, 2020 after 13 years with the University of Hawaiʻi at Mānoa.
UH research leaders agree to stand up a lab to conduct COVID-19 testing on Oʻahu.
Axel Lehrer and his lab colleagues are collaborating on developing a potential vaccine for the novel COVID-19 disease.
A John A. Burns School of Medicine student will earn his doctorate in tropical medicine this month as he works to help solve the mystery of why HIV “rebounds” when treatment is stopped or interrupted.